Skip to Content

'
Deborah A. Kuban, M.D., F.A.C.R., F.A.S.T.R.O.

Present Title & Affiliation

Primary Appointment

Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Office Address

The University of Texas M. D. Anderson Cancer Center
1515 Holcombe Blvd.
Unit Number: Unit 1202
Houston, TX 77030
Room Number: ACB P1.2864
Phone: 713-563-2329
Fax: 713-563-6940
Email: dakuban@mdanderson.org

Education & Training

Degree-Granting Education

1981 Medical College of Georgia, Augusta, GA, MD, Medicine
1977 Valdosta State College, Valdosta, GA, BS, Summa Cum Laude, Biology
1975 Carroll College, Waukesha, WI, no degree, Biology

Postgraduate Training

1/1984-6/1985 Chief Resident, Eastern Virginia Graduate School of Medicine, Department of Radiation Oncology & Physics, Norfolk, VA, Dr. Anas El-Mahdi
1/1982-6/1985 Clinical Residency, Radiation Oncology, Eastern Virginia Graduate School of Medicine, Norfolk, VA, Dr. Anas El-Mahdi
1/1981-6/1982 Clinical Internship, Surgical Internship, Graduate School of Medicine, Eastern Virginia Medical School, Norfolk, VA, Dr. James Lind

Board Certifications

1986 Therapeutic Radiology, American Board of Radiology
1981 Diplomat, National Board of Medical Examiners

Experience/Service

Administrative Appointments/Responsibilities

Medical Director, Adinterim, Genitourinary Center, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 9/2009-present
Special Assistant to the EVP/PIC, M. D. Anderson Physicians Network, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2009-present
Medical Director, Patient Affairs, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 9/2007-present
Faculty Host Advocate, M.D. Anderson Physicians Network, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 1/2006-present
Medical Director, Multi-disciplinary Prostate Cancer Clinic, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 3/2004-present
Deputy Medical Director, Genitourinary Center, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 3/2004-present
Genitourinary Section Chief, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 6/2001-present
Medical Staff, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 8/2000-present

Consultantships

Advisory Board Member, Calypso Medical Scientific Advisory Board, Seattle, WA, 2002-present

Institutional Committee Activities

Member, Clinical Effectiveness Subcommitte of the Medical Practice Committe, Working Group on Prostate, Bladder and Testicular Cancer., 2008-present
Member, Genitourinary Center Survivorship Committee, 2008-present
Member, Faculty Search Committee Department of General Internal Medicine, 2008-present
Member, Radiation Oncology Divisional Recruitment Committee, 2007-present
Member, Radiation Oncology Promotion and Tenure Committee, 2007-present
Member, Cancer Survivorship Steering Committee, 2007-2009
Member, MDAPN Credentials Committee, 2006-present
Member, Institutional Promotion and Tenure Committee, 2006-2009
Member, Division Leadership Committee, Radiation Oncology Department, 10/2003-present
Member, GU Center Clinical Protocol Priority List Committee, 2003-present
Member, Clinical Research Impact Subcommittee of the Clinical Council, 2002-present
Member, Genitourinary Center Steering Committee, 2001-present

Honors and Awards

2008 International Who's Who of Professional & Business Women, The American Biographical Institute
2007 Fellow, American Society for Therapeutic Radiology and Oncology
2007 Leading Health Professionals of the World, Cambridge, England
2006 Fellow, American College of Radiology

Professional Memberships

American Board of Radiology
Oral Board Examiner, 1994-present
American College of Radiology
Member, Appropriateness Criteria Update, 2005-present
American College of Radiology
Member, Imaging Network Genitourinary Committee, 2004-2006
American College of Radiology
Member, Commission on Quality and Safety, 2003-present
American Society for Therapeutic Radiology and Oncology
Genitourinary Category Chair, 2004-2006
American Society for Therapeutic Radiology and Oncology
Vice Chair, Annual Meeting and Program Committee, 2004-2006
American Society for Therapeutic Radiology and Oncology
Annual Meeting Abstract Reviewer, 2003-2006
American Society for Therapeutic Radiology and Oncology
Vice-Chair, Annual Meeting Scientific Program Sub-Committee, 2001-2006
American Society for Therapeutic Radiology and Oncology Research Council
Evidence-based clinical practice guideline: Role of post-operative radiotherapy for radical prostatectomy panel, Member, 2007-present
American Society for Theraputic Radiology and Oncology/ Corporate Relations Committee of the Education Council
Vice-Chair, 2008-present
Member, 2006-present
American Society of Clinical Oncology
Member, Roster of Cancer Experts, 2005-present
American Society of Clinical Oncology/American Society for Therapeutic Radiology and Oncology/Society of Urologic Oncology
Steering Committee Chair, 2009-present
Program Chair, Prostate Cancer Symposium Program Committee, 2007
Chair-elect, Prostate Cancer Symposium Program Committee, 2006
Member Prostate Cancer Symposium Program Committee, 2005-2007
American Urological Association
Member, Prostate-Specific antigen Best Practice Policy Update Panel, 2006-present
ARRO Annual Meet the Professor Luncheon
Member, 2000-present
National Comprehensive Cancer Network
Member, Bladder Cancer Guidelines Panel, 2007-present
Patterns of Care, National Survey of Practice Patterns and Outcome Studies in Radiation Oncology
Member, Genitourinary Subcommittee, 1994-2006
Quality Research in Radiation Oncology Committee (QRRO)
Member, 2007-present
Radiation Oncology Institute, Campaign Cabinet
Member, 2008-present
Radiation Therapy Oncology Group
Member, Genitourinary Committee, 2001-present
Texas Medical Society
Member, 2008-present

Selected Publications

Peer-Reviewed Original Research Articles
1. Frank SJ, Kudchadker R, Kuban DA, DeCrevoisier R, Lee AK, Cheung MR, Choi S, Tucker SL, Dong L,. A Volumetric Trend Analysis of the Prostate and Seminal Vesicles during the Course of Intensity-Modulated Radiation Therapy. Am J Clin Onc. In Press.
2. Montie JE, Clark PE, Eisenberger MA, El-Galley R, Greenberg RE, Herr HW, Hudes GR, Kuban DA, Kuzel TM, Lange PH, Lele SM, Michalski J, Patterson A, Pohar KS, Richie JP, Sexton WJ, Shipley WU, Small EJ, Trump DL, Walther PJ, Wilson TG, Wilson TG. Bladder cancer. J Natl Compr Canc Netw 7(1):8-39, 2009. PMID: 19176203.
3. Tu SM, Lopez A, Leibovici D, Bilen M, Evliyaoglu F, General RD, Aparicio A, Pagliaro LC, Guo CC, Kuban DA, Johnson MM, Logothetis CJ, Lin SH, Pisters LL. Ductal Adenocarcinoma of the Prostate - Clinical Features and Implications After Local Therapy. Cancer 115(13):2872-80, 2009. PMID: 19402048.
4. Frank SJ, Levy LB, Kuban DA, Lee AK, Kudchadker RJ, Bruno TL, Vulpen MV, Swanson DA. Prostogram Predicted Brachytherapy Outcomes are Not Universally Accurate: An Analysis Based on the M. D. Anderson Cancer Center Experience With (125)Iodine Brachytherapy. J Urol 181(4):1658-63, 2009. PMID: 19233434.
5. Lawton C, Michalski J, El-Naqa I, Kuban D, Lee W, Rosenthal S, Zietman A, Sandler H, Shipley W, Ritter M, Valicenti R, Cattan C, Roach M, Pisansky T, Seider M.. Variation in the Definition of Clinical Target Volumes for Pelvic Nodal Conformal Radiation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys 74(2):377-82, 2009. PMID: 18947941.
6. Trabulsi EJ, Valicenti RK, Hanlon AL, Pisansky TM, Sandler HM, Kuban DA, Catton CN, Muchalski JM, Zefelsky MJ, Kupelian PA, Lin DW, Anscher MS, Slawin KM, Roehrborn CG, Forman JD, Liauw SL, Kestin L, Deweese TL. Scardino PT, Stephenson AJ, Pollack A. A Multi-Institutional Matched-Control Analysis of Adjuvant and Salvage Postperative Radiation Therapy for pT3-4N0 Prostate Cancer. Urology 72(6):1298-302, 2008. PMID: 18672274.
7. O'Daniel, Dong L, Zhang J, Wang C, Tucker S, Kudchadker R, Lee AK, Cheung MR, Cox J, Kuban D, Mohan R. Daily bone alignment with limited repeat CT correction rivals daily ultrasound alignment for prostate radiotherapy. Int J Radiat Oncol Biol Phys 71(1):274-280, 2008.
8. Kudchadker RJ, Swanson DA, Kuban DA, Lee AK, Bruno TL, Frank SJ. Is a Loose-Seed Nomogram Still Valid for Prostate Brachytherapy in a Stranded-Seed Era? Int J Radiat Oncol Biol Phys. 72(2):623-7, 2008. PMID: 18410998.
9. Kuban DA, Tucker SL, Dong L, Starkschall G, Huang EH, Cheung MR, Lee AK, Pollack A. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70(1):67-74, 2008. PMID: 17765406.
10. Wang H, Garden AS, Zhang L, Wei X, Ahamad A, Kuban DA, Komaki R, O'Daniel J, Zhang Y, Mohan R, Dong L. Performance evaluation of automatic anatomy segmentation algorithm on repeat or four-dimensional computed tomography images using deformable image registration method. Int J Radiat Oncol Biol Phys 72(1):210-9, 2008. PMID: 18722272.
11. Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, Mahadevan A, Klein E, Kibel A, Pisters LL, Kuban D, Kaplan I, Wood D, Ciezki J, Shah N, Wei JT. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358(12):1250-61, 2008. PMID: 18354103.
12. Frank SJ, Dong L, Kudchadker RJ, De Crevoisier R, Lee AK, Cheung R, Choi S, O'Daniel J, Tucker SL, Wang H, Kuban DA. Quantification of prostate and seminal vesicle interfraction variation during IMRT. Int J Radiat Oncol Biol Phys 71(3):813-20, 2008. PMID: 18207664.
13. Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA. An assessment of quality of life following radical prostatectomy, high-dose external beam radiation therapy, and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J Urol 177(6):2151-6, 2007. PMID: 17509305.
14. de Crevoisier R, Melancon AD, Kuban DA, Lee AK, Cheung RM, Tucker SL, Kudchadker RJ, Newhauser WD, Zhang L, Mohan R, Dong L. Changes in the Pelvic Anatomy After an IMRT Treatment Fraction of Prostate Cancer. Int J Radiat Oncol Biol Phys 68(5):1529-36, 2007. PMID: 17544595.
15. Zhang X, Dong L, Lee AK, Cox JD, Kuban DA, Zhu RX, Wang X, Li Y, Newhauser WD, Gillin M, Mohan R. Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment. Int J Radiat Oncol Biol Phys 67(2):620-9, 2007. PMID: 17236979.
16. Frank SJ, Grimm PD, Sylvester JE, Merrick GS, Davis BJ, Zietman A, Moran BJ, Beyer DC, Roach M, Clarke DH, Stock RG, Robert Lee W, Michalski JM, Wallner KE, Hurwitz M, Potters L, Kuban DA, Prestidge BR, Vera R, Hathaway S, Blasko JC. Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: A survey of practice patterns in the United States. Brachytherapy 6(1):2-8, 2007. PMID: 17284379.
17. Cheung MR, Tucker SL, Dong L, de Crevoisier R, Lee AK, Frank S, Kudchadker RJ, Thames H, Mohan R, Kuban D. Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 67(4):1059-65, 2007. PMID: 17241755.
18. Melancon AD, O'Daniel JC, Zhang L, Kudchadker RJ, Kuban DA, Lee AK, Cheung RM, de Crevoisier R, Tucker SL, Newhauser WD, Mohan R, Dong L. Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer? Radiother Oncol 85(2):251-259, 2007. PMID: 17892900.
19. Zelefsky MJ, Kuban DA, Levy LB, Potters L, Beyer DC, Blasko JC, Moran BJ, Ciezki JP, Zietman AL, Pisansky TM, Elshaikh M, Horwitz EM. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys 67:327-33, 2007. PMID: 17084558.
20. Stephenson AJ, Scardino PT, Kattan MW, Pisansky TM, Slawin KM, Klein EA, Anscher MS, Michalski JM, Sandler HM, Lin DW, Forman JD, Zelefsky MJ, Kestin LL, Roehrborn CG, Catton CN, DeWeese TL, Liauw SL, Valicenti RK, Kuban DA, Pollack A. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. Am J Clin Oncol 25(15):2035-41, 2007. PMID: 17513807.
21. Feng M, Hanlon AL, Pisansky TM, Kuban D, Catton CN, Michalski JM, Zelefsky MJ, Kupelian PA, Pollack A, Kestin LL, Valicenti RK, Deweese TL, Sandler HM. Predictive Factors for late Genitourinary and Gastrointestinal Toxicity in Patients With Prostate Cancer Treated With Adjuvant or Salvage Radiotherapy. Int J Radiat Oncol Biol Phys 68(5):1417-23, 2007. PMID: 17418972.
22. Vance W, Tucker SL, de Crevoisier R, Kuban DA, Cheung MR. The predictive value of 2-year posttreatment biopsy after prostate cancer radiotherapy for eventual biochemical outcome. Int J Radiat Oncol Biol Phys 67(3):828-33, 2007. PMID: 17161554.
23. Vassiliev ON, Kry SF, Kuban DA, Salehpour M, Mohan R, Titt U. Treatment-planning study of prostate cancer intensity-modulated radiotherapy with a Varian Clinac operated without a flattening filter. Int J Radiat Oncol Biol Phys 68(5):1567-71, 2007. PMID: 17544596.
24. Kry SF, Followill D, White RA, Stovall M, Kuban DA, Salehpour M. Uncertainty of calculated risk estimates for secondary malignancies after radiotherapy. Int J Radiat Oncol Biol Phys 68(4):1265-71, 2007. PMID: 17637398.
25. Gao S, Zhang L, Wang H, de Crevoisier R, Kuban DD, Mohan R, Dong L. A deformable image registration method to handle distended rectums in prostate cancer radiotherapy. Med Phys 33(9):3304-12, 2006. PMID: 17022225.
26. Horwitz EM, Levy LB, Thames HD, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Sandler HM, Shipley WU, Zelefsky MJ, Zietman AL, Kuban DA. Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis. Cancer 107:1496-502, 2006. PMID: 16944536.
27. Tucker SL, Zhang M, Dong L, Mohan R, Kuban D, Thames HD. Cluster model analysis of late rectal bleeding after IMRT of prostate cancer: a case-control study. Int J Radiat Oncol Biol Phys 64(4):1255-64, 2006. PMID: 16504763.
28. Kuban DA. Does postoperative adjuvant radiotherapy reduce biochemical progression after radical prostatectomy? Nat Clin Pract Urol 3:70-1, 2006. PMID: 16470200.
29. O'Daniel JC, Dong L, Zhang L, de Crevoisier R, Wang H, Lee AK, Cheung R, Tucker SL, Kudchadker RJ, Bonnen MD, Cox JD, Mohan R, Kuban DA. Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 66(3):883-91, 2006. PMID: 17011461.
30. Cheung R, Tucker SL, Kuban DA. First-year PSA kinetics and minima after prostate cancer radiotherapy are predictive of overall survival. Int J Radiat Oncol Biol Phys 66(1):20-4, 2006. PMID: 16814948.
31. deCrevoisier R, Kuban D, Lefkopoulos D. Image-guided radiotherapy by in-room Ct-linear accelerator combination. Cancer Radiotherapy 10:245-51, 2006.
32. Thames HD, Kuban DA, DeSilvio ML, Levy LB, Horwitz EM, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Sandler HM, Shipley WU, Zelefsky MJ, Zietman AL. Increasing external beam dose for T1-T2 prostate cancer: effect on risk groups. Int J Radiat Oncol Biol Phys 65(4):975-81, 2006. PMID: 16750319.
33. Strom SS, Kamat AM, Gruschkus SK, Gu Y, Wen S, Cheung MR, Pisters LL, Lee AK, Rosser CJ, Kuban DA. Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer. Cancer 107(3):631-9, 2006. PMID: 16802288.
34. Ray ME, Levy LB, Horwitz EM, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Zelefsky MJ, Zietman AL, Kuban DA. Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure. Urology 68:1257-62, 2006. PMID: 17141830.
35. Ray ME, Thames HD, Levy LB, Horwitz EM, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Shipley WU, Zelefsky MJ, Zietman AL, Kuban DA. PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis. Int J Radiat Oncol Biol Phys 64:1140-50, 2006. PMID: 16198506.
36. Court LE, Dong L, Lee AK, Cheung R, Bonnen MD, O'Daniel J, Wang H, Mohan R, Kuban D. An automatic CT-guided adaptive radiation therapy technique by online modification of multileaf collimator leaf positions for prostate cancer. Int J Radiat Oncol Biol Phys 62:154-63, 2005. PMID: 15850916.
37. Cheung R, Tucker SL, Lee AL, Dong L, Kamat A, Pisters L, Kuban DA. Assessing the impact of an alternative biochemical failure definition on radiation dose response for high-risk prostate cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys 61:14-9, 2005. PMID: 15629589.
38. Lee CT, Dong L, Ahamad AW, Choi H, Cheung R, Lee AK, Horne DF, Jr, Breaux AJ, Kuban DA. Comparison of treatment volumes and techniques in prostate cancer radiation therapy. Am J Clin Oncol 28:618-25, 2005. PMID: 16317275.
39. Kuban DA, Thames HD, Shipley WU. Defining recurrence after radiation for prostate cancer. J Urol 173:1871-8, 2005. PMID: 15879766.
40. Horwitz EM, Thames HD, Kuban DA, Levy LB, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Sandler HM, Shipley WU, Zelefsky MJ, Hanks GE, Zietman AL. Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis. J Urol 173:797-802, 2005. PMID: 15711272.
41. Cheung R, Tucker SL, Lee AK, de Crevoisier R, Dong L, Kamat A, Pisters L, Kuban D. Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys 61:993-1002, 2005. PMID: 15752878.
42. Kuban D, Thames H, Levy L, Horwitz E, Kupelian P, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A. Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all? Int J Radiat Oncol Biol Phys 61:409-14, 2005. PMID: 15667960.
43. Wang H, Dong L, Lii MF, Lee AL, de Crevoisier R, Mohan R, Cox JD, Kuban DA, Cheung R. Implementation and validation of a three-dimensional deformable registration algorithm for targeted prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 61:725-35, 2005. PMID: 15708250.
44. Kupelian P, Kuban D, Thames H, Levy L, Horwitz E, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995. Int J Radiat Oncol Biol Phys 61:415-9, 2005. PMID: 15667961.
45. de Crevoisier R, Tucker SL, Dong L, Mohan R, Cheung R, Cox JD, Kuban DA. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 62:965-73, 2005. PMID: 15989996.
46. Rosser CJ, Kamat AM, Wang X, Do KA, Sanchez-Ortiz RF, Kuban DA, Lee AK, Cheung R, Chichakli R, Pisters LL. Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate cancer? Urology 66:327-31, 2005. PMID: 16040084.
47. Kry SF, Salehpour M, Followill DS, Stovall M, Kuban DA, White RA, Rosen,, II. Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 62:1204-16, 2005. PMID: 15990026.
48. Cheung R, Kamat AM, de Crevoisier R, Allen PK, Lee AK, Tucker SL, Pister L, Babaian RJ, Kuban D. Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy. Int J Radiat Oncol Bio Phys 63:134-140, 2005.
49. Lee AK, Levy LB, Cheung R, Kuban D. Prostate-specific antigen doubling time predicts clinical outcome and survival in prostate cancer patients treated with combined radiation and hormone therapy. Int J Radiat Oncol Biol Phys 63:456-62, 2005. PMID: 15927415.
50. Leibovici D, Lee AK, Cheung RM, Spiess PE, Kuban DA, Rosser CJ, Shen Y, Yang Y, Chichakli R, Pisters LL. Symptomatic local recurrence of prostate carcinoma after radiation therapy. Cancer 103:2060-6, 2005. PMID: 15822114.
51. Kry SF, Salehpour M, Followill DS, Stovall M, Kuban DA, White RA, Rosen,, II. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 62:1195-203, 2005. PMID: 15990025.
52. Mohan R, Zhang X, Wang H, Kang Y, Wang X, Liu H, Ang KK, Kuban D, Dong L. Use of deformed intensity distributions for on-line modification of image-guided IMRT to account for interfractional anatomic changes. Int J Radiat Oncol Biol Phys 61:1258-66, 2005. PMID: 15752908.
53. Wang H, Dong L, O'Daniel J, Mohan R, Garden AS, Ang KK, Kuban DA, Bonnen M, Chang JY, Cheung R. Validation of an accelerated 'demons' algorithm for deformable image registration in radiation therapy. Phys Med Biol 50:2887-905, 2005. PMID: 15930609.
54. Kupelian P, Thames H, Levy L, Horwitz E, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A, Kuban D. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys 63:795-9, 2005. PMID: 15925452.

Invited Articles
1. Carducci MA, Montie JE, Kuban DA. Perspectives on the Management of Localized Prostate Cancer. American Society of Clinical Oncology, Educational Book, 2009.
2. Kuban DA, Dong L, Cheung R, Strom E, De Crevoisier R. Ultrasound-based localization. Semin Radiat Oncol 15:180-91, 2005. PMID: 15983943.

Editorials
1. Kuban DA, Pagliaro L. Salvage Radiotherapy or Observation After Radical Prostatectomy in the PSA era. The American Journal of Hematology/Oncology. 8(3):136-138, 2009.
2. Kuban DA. Reconsidering the case for brachytherapy plus EBRT in high-risk prostate cancer. Oncology 22:1006-1012, 2008.
3. Kuban Deborah A. Does Postoperative Adjuvant Radiotherapy Reduce Biochemical Progression after Radical Prostatectomy? Nat Clin Pract Urol 3(2):70-1, 2006. PMID: 16470200.
4. Kuban DA. Permanent prostate brachytherapy: Is supplemental external-beam radiation therapy necessary? Oncology 20:522-523, 2006.
Other Articles
1. Kuban DA. Book Review of Image-Guided Radiation Therapy of Prostate Cancer. Int J Rad Oncol Biol Phys, 2008.

Abstracts
1. Davis JW, Troncoso P, Ward J, Pettaway C, Pisters L, Kuban D, Brown V, Lothetis C, Kim J. Active Surveillance for Localized Prostate Cancer -- A Prospective Protocol. J Urol 181(4):Suppl 1, 2009.
2. Parker PA, Latini DM, Ward JF, Pettaway C, Pisters LL, Matin S, Frank SJ, Brown V, Kuban DA, Logothetis C, Kim J, Davis JW. Associations Between Uncertainty, Anxiety, and Quality of Life in Men With Prostate Cancer on Active Surveillance. Annals of Behavioral Medicine 37 (#2122), 2009.
3. Oleg V, Kudchadker RJ, Kuban DA, Lee AK. Dosimetric Impact of Gold Fiducial Markers in Patients Undergoing External Beem Radiation Therapy. Proceedings of AAPM, 2009.
4. Ludwig MS, Kuban DA,. Intermediate Risk Prostate Cancer, Outcomes Related to Radiation Dose and the Use of Hormone Therapy. Proceedings of The 91st Annual Meeting of The American Radium Society, 2009.
5. Leibovici D, Tu SM, Lopez A, Pagliaro LC, Kuban DA, Logothetis CJ, Pisters LL. The Specific Clinical Charachteristics of Ductal Prostate Cancer. J Urol 181(4):Suppl 1, 2009.
6. Madsen L, Kim J, Craig C, Cheung MR, Kuban DA. A Senior Multidisciplinary Prostate Cancer Clinic - Identifying The Patient Population and Addressing The Treatment Goals. Proceedings of The Oncology Nursing Forum, 11/2008.
7. Phan J, Swanson DA, Kuban DA, Lee AK, Cheung R, Choi S, Kudchadker R, Bruno T, Levy LB and Frank SJ. Long-Term rectal complications following permanent prostate brachytherapy at the University of Texas M.D. Anderson Cancer Center. Proceedings from 94th Scientific Assembly and the Annual Meeting of The Radiologic Society of North America, 11/2008.
8. Davis J, Troncoso P, Ward J, Babaian J, Pettaway C, Pisters l, Kuban D, Brown V, Logothetis C, Kim J. Active surveilence for clinically localized prostate cancer at high volume tertiary refferal center. J Urol(179(4)), 2008.
9. Kuban DA, Levy LB, Tucker S, Lee AK, Choi S, Cheung MR, Frank SJ, Pollack A. Long-Term Failure Patterns and Survival in a Randomized Dose Escalation Trial for Prostate Cancer. Who Dies of Disease? Int J Rad Oncol Biol Phys 72(1):S95 (#206), 2008.
10. Choi S, Frank SJ, Cheung MR, Lee AK, Kuban DA. Outcome After External beam Radiation Therapy for Prostate Cancer Patients under 60 Years of Age. Int J Rad Onc 72(1) (#2285), 2008.
11. Frank S, Swanson D, Kuban D, Lee A.Levy L,. Postogram-predicted brachytherapy outcomes may not be universally accurate: An analysis based on the M. D. Anderson Cancer Center experience with I-125 brachytherapy. Proceedings of the 2008 ASCO, ATRO, SUO Genitourinary Cancers Symposium(157(#124)), 2008.
12. Frank SJ, Fisher C, Levy L, Kudchadker R, Kuban DA, lee AK, Cheung MR, Choi S, Bruno T, Swanson DA. Pre-Implant Urinary Symptoms Predict for Worse Genderual Outcomes. Int J Rad Oncol Biol Phys 72(1) (#2745), 2008.
13. Frank SJ, Kuban DA, Lee AK, Levy LB, Kudchadker R, Brino T, Swanson DA. Prostate Brachytherapy - The M. D. Anderson Cancer Center Experience. J Urol(174(4)):396-397 (#1161), 2008.
14. Vassiliev ON, Kudchadker RJ, Swanson DA, Kuban DA, Bruno TL, Frank SJ. Systematic Evaluation of Periurethral Stranded Seed Migration and its Dosimetric Consequenses in Prostate Brachytherapy. Int J Rad Onc Biol Phys 72(1) (#2922), 2008.
15. Iyengar P, Levy LB, Lee AK, Cheung MR, Choi S, Frank SJ, Kuban DA. Toxicity Associated with Post Operative Radiation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys 1(72) (#2404), 2008.
16. O'Daniel JC, Dong L, Kudchadker RJ, Kuban DA, de Crevoisier R, Lee AK, Cheung R, Zhang L, Tucker SL, Mohan R. Daily bone alignment with limited repeat CT correction rivals daily ultrasound alignment for prostate radiotherapy. Int J Radiat Oncol Biol Phys 69:S639, 2007.
17. Madsen L, Craig C, Williams J, Kuban D. Developing a Multidisciplinary Prostate Cancer Clinic for the Newly Diagnosed Prostate cancer Population-defining the role of an oncology APN. Proceedings of the Oncology Nursing Society (#2480), 2007.
18. Cheung MR, Tucker SL, Dong L, Bosch WR, Michalski J, Winter K, Mohan R, Kuban D, Lee AK, Cox JD. Dose-volume analyses pf grade > 2 late rectal toxicity among patients treated on protocol RTOG 94-06. Int J Radiat Oncol Biol Phys 69:S9, 2007.
19. Tucker SL, Dong L, Bosch WR, Michalski J, Winter K, Lee AK, Cheung MR, Kuban DA, Cox JD, Mohan R. Fit of a generalized Lyman normal-tissue complication probability (NTCP) model to grade > 2 late rectal toxicity data from patients treated on protocol RTOG 94-06. Int J Radiat Oncol Biol Phys 69:S8, 2007.
20. Huang E, Pollack A, Levy L, Starkschall G, Dong L, Rosen II, Kuban DA. Late rectal toxicity: Dose-volume effects of conformal radiotherapy for prostate cancer. Health & Safety Science Abstracts, 2007.
21. Sanda MG, Dunn RL, Michalski J, Sandler HM, Hembroff L, Litwin MS, Saigal CS, Mahadevan A, Klein EA, Kibel AS, Pisters LL, Kuban D, Kaplan I, Ciezki JP, Wei JT,. Prostate size, obesity, and neoadjuvant hormone therapy affect HRQOL in a prospective, multi-center study of prostatectomy, external radiotheapy, or brachytherapy for prostate cancer. J Urol(177) (#1772), 2007.
22. Lee AK, Kudchadker RJ, Amos RA, Johnson JL, Choi SL, Kuban DA, Cox JD, Mohan R, Gillin M, Dong L. Proton therapy vs. IMRT for prostate cancer: A dosimetric comparison. Int J Radiat Oncol Biol Phys 69:S342, 2007.
23. Horwitz EM, Hanlon AL, Pisansky TM, Sandler HM, Kuban DA, Catton C, Michalski JM, Stephenson A, Pollack A, Post-Prostatectomy Radiation Therapy Consortium. The Phoenix definition of biochemical failure correlates with clinical failure for men treated with adjuvant and salvage post-prostatectomy radiation: Results of the multi-institutional pooled analysis. Int J Radiat Oncol Biol Phys 69:S173 (#1064), 2007.
24. Lawton CA, Michalski J, El-Naqa I, Kuban D, Lee WR, Rosenthal S, Zietman A, Sandler H, Roach M. Variation in the definition of clinical target volumes for pelvic node conformal radiation therapy of prostate cancer. Int J Radiat Oncol Biol Phys 69:S327, 2007.
25. Stephenson AJ, Pollack A, Scardino PT, Kattan MW, Pisansky TM, Slawin KM, Klein EA, Kupelian PA, Anscher MS, Michalski JM, Sandler HM, Zelefsky MJ, Forman JD, Lin DW, Kestin LL, Pistenmaa DA, Catton CN, Deweese TL, Valicienti RK, Kuban DA, Bianco FJ, Fearn PA. A nomogram to predict the outcome of salvage radiotherapy (RT) for biochemical recurrence (BCR) following radical prostatectomy (RP). J Urol 175:S384, 2006.
26. O'Daniel J, Dong L, Zhang L, Wang H, Tucker S, Kudchadker R, de Crevoisier R, Lee A, Cheung R, Kuban D, Mohan R. Dosimetric comparison of the no action level alignment protocol with daily alignment techniques for prostate cancer. Proceedings of The AAPM Meeting, 2006.
27. Michalski JM, Ciezki J, Kaplan I, Kuban D, McLaughlin PW, Sandler H, Lee S, Dunn R, Wei J, Sanda M. Early complications following contemporary brachytherapy for prostate cancer in a multi-institutional study at high volume health centers in the US. Int J Radiat Oncol Biol Phys 66:S323, Abstract #2204, 2006.
28. Lopez CA, Michalski JM, Kuban D, Mahadevan A, Kaplan ID, Lee SP, Zietman AL, Suh WW, Dunn RL, Sandler HM. Early complications following contemporary brachytherapy for prostate cancer in a multi-institutional study at high volume health centers in the US. Int J Radiat Oncol Biol Physics 66:S344, Abstract #2241, 2006.
29. Cheung R, Tucker S, de Crevoisier R, Lee A, Frank S, Kudchadker R, Thames H, Mohan R, Kuban D. Identification of the bladder dose and volume constraints to control late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Biol Oncol Phys 66:S37-38, Abstract #64, 2006.
30. Elshaikh MA, Kuban D, Levy L, Potters L, Blasko J, Beyer D, Zietman A, Moran BJ, Ciezki J, Zelefsky MJ. Long-term multi-institutional outcome and biochemical failure definition analysis of combined permanent brachytherapy with external beam radiation for prostate cancer. Int J Radiat Oncol Biol Phys 66:S78, Abstract #101, 2006.
31. Kuban D, Tucker S, Dong L, Huang E, Lee A, Cheung R, Starkschall G, Pollack A. Long-term results of a randomized dose escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 66:S8-9, Abstract #15, 2006.
32. Sanda MG, Dunn RL, Northouse L, Litwin MS, Hembroff L, Sandler HM, Michalski J, Klein EA, Mahadevan A, Kibel AS, Saigal CS, Pisters LL, Kuban DA, Kaplan I, Wei JT. Prostate cancer physician performance measured by patient-reported ratings of practitioner manner/skill and by treatment-related adverse events. J Urol 175:S517, 2006.
33. Kry SF, Vassiliev ON, Kuban D, Poenisch F, Salehpour M, Gillin MT, Mohan R, Titt U. Prostate IMRT using unflattened beams. Int J Radiat Oncol Biol Phys 66:S78, Abstract #140, 2006.
34. Frank SJ, Pisters LL, Davis J, Lee AK, Cheung R, Swanson D, Bassett RL, Pettaway CA, Kuban DA. Quality of life after monotherapy treatment for localized prostate cancer: implant (I-125), radical prostatectomy, and high dose external beam radiation therapy. Int J Radiat Oncol Biol Phys 66:S131, Abstract #1005, 2006.
35. Horowitz EM, Levy LB, Martinez AA, Potters L, Beyer DC, Blasko JC, Sandler HM, Buskirkk SJ, Zietman AL, Kuban DA. The post-treatment PSA bounce for prostate cancer patients treated with external beam RT or permanent brachytherapy alone is not biochemically or clinically significant: a multi-institutional pooled analysis of more than 7500 patients. Int J Radiat Oncol Biol Phys 66:S205, Abstract #1129, 2006.
36. Kry SF, Vassiliev ON, Kuban D, Ponisch F, Salehpour M, Gillin MT, Mohan R, Titt U. Treatment planning study of prostate cancer IMRT with a flattering filter free accelerator. Proceedings of The AAPM Meeting, 2006.
37. Kuban DA. What is the best treatment for low and intermediate risk prostate cancer? External beam radiation. Proceedings of The Prostate Cancer Symposium, ASCO, ASTRO, SUO 54, 2006.
38. Tucker S, Thames H, Zhang M, Dong L, Mohan R, Kuban D. A case-control study of cluster size as predictor of rectal bleeding in T1-T2 prostate cancer patients treated by IMRT. Int J Radiat Oncol Biol Phys 63:S324, Abstract #2163, 2005.
39. Valicenti RK, Hanlon AL, Pisansky TM, Sandler HM, Kuban DA, Catton C, Michalski JM, Zelefsky PA, Kupelian PA, Kestin LL, DeWeese TL, Pollack A. A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3/4NO prostate cancer. Int J Radiat Oncol Biol Phys 63:S33-34, Abstract #204, 2005.
40. Melancon A, de Crevoisier R, Kuban D, Lee A, Cheung R, Zhang L, O'Daniel J, Mohan R, Cox J, Dong L. Analysis of intra-fractional variations of anatomy during prostate IMRT treatment. Int J Radiat Oncol Biol Phys 63:S562-563, Abstract #2551, 2005.
41. Vance W, Tucker S, de Crevoisier R, Kuban D, Cheung R. Assessing the utility of a 2-year post treatment biopsy for forecasting eventual biochemical failure and survival. Int J Radiat Oncol Biol Phys 63:S76-77, Abstract #1088, 2005.
42. Sanda MG, Dunn RL, Saigal CS, Klein EA, Pisters LL, Michalski JM, Kibel AS, Mahadevan A, Sandler HM, Kuban DA, Litwin MS, Wei JT. Association of race, cancer severity, pre-treatment quality of life, and patient optimism/pessimism with patient selection of primary prostate cancer treatment. J Urol 173:453, Abstract #1671, 2005.
43. Kuban DA, Levy LB, Potters L, Beyer DC, Blasko JC, Moran BJ, Ciezki JP, Zietman AL, Zelefsky MJ, Pisansky TM, Elshaikh M, Horwitz EM. Comparison of biochemical failure definitions for permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 63:S33-34, Abstract #507, 2005.
44. Kuban DA, Levy LB, Potters L, Beyer DC, Blasko JC, Moran BJ, Ciezki JP, Zietman AL, Zelefsky MJ, Pisansky TM, Elshaikh M, Horwitz EM. Comparison of biochemical failure definitions for permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 63(5):S33-34, Abstract #507, 2005. e-Pub 6/5/2006. PMID: 16750326.
45. Johnson JL, Cheung R, Dong L, Tucker SL, de Crevoisier R, Kuban D. Comparison of rectal dose-wall histograms and dose-volume histograms in predicting rectal grade toxicity after prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 63:S207, Abstract #1102, 2005.
46. O'Daniel JC, Long L, Zhang L, Wang H, de Crevoisier R, Bonnen MD, Lee AK, Cheung RM, Cox JD, Mohan R, Kuban DA. Dosimetric assessment of daily skin, bone, ultrasound and CT alignment for prostate cancer IMRT. Int J Radiat Oncol Biol Phys 63:S560-561, Abstract #2548, 2005.
47. O'Daniel J, Dong L, Zhang L, Wang C, de Crevoisier R, Bonnen M, Mohan R, Kuban D. Dosimetric comparison of skin, bone, ultrasound, and CT alignments for prostate cancer. Medical Physics, 2005.
48. Cheung R, Tucker S, Kuban D. First year PSA kinetics and nadirs after prostate radiotherapy are predictive of overall survival. Int J Radiat Oncol Biol Phys 63:S199-200, Abstract #1091, 2005.
49. de Crevoisier R, Tucker S, Dong L, Mohan R, Cheung R, Cox J, Kuban D. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 63:S293-294, Abstract #2107, 2005.
50. Zelefsky MJ, Kuban DA, Levy LB, Potters L, Beyer DC, Blasko JC, Moran BJ, Ciezki JP, Zietman AL, Pisansky T, Elshaikh M, Horwitz EM. Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with permanent brachytherapy. Int J Radiat Oncol Biol Phys 63:S33, Abstract #56, 2005.
51. Michalski, J, Wei J, Dunn R, Mahadevan A, Sandler H, Saigal C, Kuban D, Pisters L, Klein E, Litwin M, Hembroff L, Sanda M. Neoadjuvant hormone therapy (NHT) leads to immediate impairment of vitality/hormonal and sexual quality of life: Results of a multi-center prospective study. Int J Radiat Oncol Biol Phys 63:S76-77, Abstract #126, 2005.
52. Sanda MG, Dunn RL, Mahadevan A, Sandler HM, Saigal CS, Kuban DA, Michalski JM, Pisters LL, Klein EA, Kibel AS, Litwin MS, Hembroff L, Wei JT. Neoadjuvant hormone therapy (NHT) leads to immediate impairment of vitality/hormonal and sexual quality of life: Results of a multi-center prospective study. J Urol 173:223, Abstract #824, 2005.
53. Feng M, Hanlon AL, Pisansky TM, Kuban DA, Catton C, Michalski JM, Zelefsky MJ, Kupelian PA, Pollack A, Kestin LL, Valicenti RK, DeWeese TL. Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy. Int J Radiat Oncol Biol Phys 63:S127, Abstract #210, 2005.
54. Ray ME, Levy LB, Horwitz M, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Zelefsky MJ, Zietman AL, Kuban DA. PSA at 12 months after external beam radiation therapy for localized prostate cancer predicts biochemical and distant failure: A multi-institutional study. Proceeding of the 2005 Multidisciplinary Prostate Cancer Symposium, Orlando, FL, 2005.
55. Kuban DA, Zietman AL, Pisansky TM, Martinez AA, Horwitz EM, Sandler HM. Radiation therapy for Stage T1-T2 prostate cancer. Lessons from a multi-institutional analysis with long term follow-up. Proceedings of the American Radium Society 87th Annual Meeting, Barcelona, Spain, 2005.
56. Leibovici D, Lee AK, Cheung R, Kuban DA, Rosser CJ, Chichakli R, Pisters LL. Symptomatic local recurrence of prostate cancer after radiation therapy. J Urol 173:189, Abstract #694 (#694), 2005.
57. Pollack A, Hanlon AL, Pisansky TM, Sandler HM, Kuban DA, Catton C, Michalski JM, Zelefsky MJ, Kupelian PA, Kestin LL, Valicenti RK, DeWeese TL. Which definition of biochemical failure after post-operative radiotherapy predicts best for clinical failure? A multi-institutional analysis. J Urol 173:308-309, Abstract #1136, 2005.

Book Chapters
1. Logothetis CJ, Troncoso P, Kim J, Davis JW, Kuban DA, Mathew P, Aparicio A. Prostate Cancer. In: Cancer Medicine 8th Edition. PMPH-USA: Shelton, CT. In Press.
2. Kuban DA, Trad ML. Male Reproductive and Genitourinary Tumors. In: Principals and Practice of Radiation Therapy. Mosby, 2009.
3. Kuban DA, Cheung R, Meistrich ML, Hussey DH. The Testicle. In: Radiation Oncology: Rationale, Technique, Results. Mosby, Inc. St. Louis, MO, 2009.
4. Kuban DA, Potters L, Lawton CA, Pisansky TM. Prostate Cancer. In: Clinical Radiation Oncology. Churchill Livingston an imprint of Elsevier, Inc. Philadelphia, PA, 2007.

Letters to the Editor
1. Kuban DA. In reply to Drs. Schulz and Kagan. Int J Radiat Oncol Biol Phys. 71(4):1288, 2008.

Manuals, Teaching Aids, Other Teaching Publications
1. Kuban DA. Treatment Options, Multidisciplinary Prostate Cancer: Patient Educational Materials, 2008.
 

Other
1. U.T. M.D. Anderson Website. "Genitourinary Radiation Guide", 2003.
2. U.T. M.D. Anderson Cancer Center Website. Production and Editing Video - "How to Treat Cancer", 2004-2005.
3. Consultant for Genitourinary Center Website. Prostate Cancer, Kidney Cancer, Bladder Cancer,and Testicular Cancer, 2004-2005.
4. Video. Participant in video on Prostate Cancer, supported by Texas Health Council, 2004-2005.
5. Clinical Guidelines,. Development and update of M. D. Anderson Clinical Guidelines for Prostate, Bladder and Renal Cancer, 2001 - present.
6. U.T. M.D. Anderson Website. Multidisciplinary Prostate Cancer Clinic.

Last updated: 9/4/2009